Exogenous IL-13 exacerbates Leishmania major infection and abrogates acquired immunity to re-infection

Parasitol Res. 2022 Jul;121(7):2009-2017. doi: 10.1007/s00436-022-07539-y. Epub 2022 May 10.

Abstract

Cutaneous leishmaniasis is a major global health issue, affecting more than 88 countries with 0.7-1.2 million new cases per year. T helper polarization plays a significant role in disease outcome, with Th1 responses being associated with resistance and Th2 responses being associated with susceptibility. IL-13 is an important Th2 cytokine with structural and functional similarities to IL-4. In this study, we demonstrate that administering exogenous IL-13 to Leishmania major-infected BALB/c mice increases parasite load in the infected paw and decreases tissue levels of the key Th1/Th2 cytokines IFN-γ and IL-4, respectively. Infecting BALB/c mice with a low dose of L. major has previously been shown to confer resistance to re-infection with a higher dose. In this study, we demonstrate that administration of exogenous IL-13 early in the course of the initial low-dose infection abrogates acquired resistance to high-dose re-infection, as measured by infected paw thickness.

Keywords: Interleukin-13; Leishmania; Leishmaniasis; T helper polarization.

MeSH terms

  • Adaptive Immunity
  • Animals
  • Cytokines
  • Interleukin-13
  • Interleukin-4
  • Leishmania major*
  • Leishmaniasis, Cutaneous*
  • Mice
  • Mice, Inbred BALB C
  • Reinfection
  • Th1 Cells
  • Th2 Cells

Substances

  • Cytokines
  • Interleukin-13
  • Interleukin-4